March 31, 2026 16:06 ET | Source: BioAtla, Inc. SAN DIEGO, March 31, 2026 (GLOBE NEWSWIRE) -- BioAtla, Inc. (NASDAQ:…
– Released positive topline data from Phase 1 study of IV rademikibart in patients with asthma or COPD – –…
The American Society for Clinical Oncology to be held in Chicago May 29 – June 2, 2026 March 31, 2026…
REYKJAVIK, ICELAND (March 30, 2026) — Alvotech (NASDAQ: ALVO) (the “Company”) has filed its Annual Report 2025 on Form 20-F for…
REYKJAVIK, ICELAND (March 30, 2026) — Alvotech (NASDAQ: ALVO) (the “Company”) has published its Annual Report for 2025. The report is…
Aurora, CO, March 30, 2026 (GLOBE NEWSWIRE) -- This article contains affiliate links. If a purchase is made through these…
NEW ORLEANS, March 29, 2026 (GLOBE NEWSWIRE) -- Medical AI, a company specializing in artificial intelligence-enabled electrocardiogram (ECG) solutions for…
Results from the Phase 3 VELA clinical trials in adults with moderate-to-severe hidradenitis suppurativa (HS) show that clinical responses continue…
March 28, 2026 15:00 ET | Source: Roivant Sciences The results of the Phase 3 VALOR trial were published in…
“Persistent kidney inflammation is a hallmark of IgAN, and a key driver of disease progression, leading to ongoing kidney damage…